Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Tomelleri

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Blood|June 2, 2021
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester diseaseRaffaella Molteni, Riccardo Biavasco, Davide Stefanoni, et al.
British Journal of Haematology|November 13, 2024
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndromeCarmelo Gurnari, Elisa Galossi, Eleonora Lumia, et al.
Cell Reports. Medicine|April 27, 2022
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failureEvangelos J Giamarellos-Bourboulis, Garyfallia Poulakou, Aline de Nooijer, et al.
American Journal of Hematology|December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohortCarmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Annals of the Rheumatic Diseases|June 13, 2025
Exploring the limit of image resolution for human expert classification of vascular ultrasound images in giant cell arteritis and healthy subjects: the GCA-US-AI projectClaus-Juergen Bauer, Stavros Chrysidis, Christian Dejaco, et al.
Rheumatology (Oxford, England)|August 7, 2021
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patientsArsène Mekinian, Lucie Biard, Lorenzo Dagna, et al.
RMD Open|June 15, 2023
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective studyArsène Mekinian, Lucie Biard, Dagna Lorenzo, et al.
Rheumatology (Oxford, England)|August 14, 2025
Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective studyArsène Mekinian, Sarah Meneses, Lucie Biard, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Annals of the Rheumatic Diseases|January 4, 2023
The provisional OMERACT ultrasonography score for giant cell arteritisChristian Dejaco, Cristina Ponte, Sara Monti, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Blood|June 2, 2021
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester diseaseRaffaella Molteni, Riccardo Biavasco, Davide Stefanoni, et al.
British Journal of Haematology|November 13, 2024
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndromeCarmelo Gurnari, Elisa Galossi, Eleonora Lumia, et al.
Cell Reports. Medicine|April 27, 2022
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failureEvangelos J Giamarellos-Bourboulis, Garyfallia Poulakou, Aline de Nooijer, et al.
American Journal of Hematology|December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohortCarmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Annals of the Rheumatic Diseases|June 13, 2025
Exploring the limit of image resolution for human expert classification of vascular ultrasound images in giant cell arteritis and healthy subjects: the GCA-US-AI projectClaus-Juergen Bauer, Stavros Chrysidis, Christian Dejaco, et al.
Rheumatology (Oxford, England)|August 7, 2021
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patientsArsène Mekinian, Lucie Biard, Lorenzo Dagna, et al.
RMD Open|June 15, 2023
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective studyArsène Mekinian, Lucie Biard, Dagna Lorenzo, et al.
Rheumatology (Oxford, England)|August 14, 2025
Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective studyArsène Mekinian, Sarah Meneses, Lucie Biard, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Annals of the Rheumatic Diseases|January 4, 2023
The provisional OMERACT ultrasonography score for giant cell arteritisChristian Dejaco, Cristina Ponte, Sara Monti, et al.
Pageof 13